Potential Drug Target Or Biomarker Gene BAF123 Discovered on Chromosome 10

Target Name: Chromosome 10 open reading frame 115

NCBI ID: G387642

Chromosome 10 open reading frame 115

Other Name(s): bA215C7.4 | C10orf115

Potential Drug Target Or Biomarker Gene BAF123 Discovered on Chromosome 10

Chromosome 10 open reading frame 115 (bA215C7.4) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic variation has led to a growing interest in its potential as a therapeutic target, with researchers investigating its role in the development and progression of these diseases.

The open reading frame (ORF) is a stretch of DNA on a chromosome that is involved in the production of proteins. ORFs are often targeted by drugs because they are typically rich in protein-coding genes, which can be easily modified to produce specific proteins that can interact with drugs. The bA215C7.4 gene on chromosome 10 is one such gene, and its unique ORF has made it an attractive target for researchers.

The bA215C7.4 gene is located in the open reading frame (ORF) on chromosome 10, specifically at position 115. It is a gene that encodes a protein known as BAF123, which is a member of the TIR family of proteins. BAF123 is involved in various cellular processes, including cell adhesion, migration, and invasion, and is a potential drug target for various diseases.

One of the reasons why BAF123 is a promising drug target is its unique genetic variation. The BAF123 gene has been identified as having a single nucleotide polymorphism (SNP) at position 215, which results in the substitution of a thymine (T) for a guanine (G) at that position. This SNP has led to the production of a unique protein that has different stability and activity than the original protein.

The fact that a single SNP can result in such a significant change in the structure and function of a protein is significant. It indicates that BAF123 is a very flexible protein that can be easily modified to interact with drugs. Furthermore, the fact that the SNP has led to the production of a protein that is different from the original protein suggests that it may have different effects than the original protein.

Research has shown that BAF123 is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key target for many diseases, including cancer.

In addition to its involvement in cellular signaling pathways, BAF123 is also involved in the regulation of the cytoskeleton. The cytoskeleton is the structure that organizes the cells, and is involved in many cellular processes, including cell division, movement, and stability. BAF123 is involved in the regulation of the cytoskeleton in order to ensure that cells maintain their proper structure and function.

The potential drug targets for BAF123 are vast. Its involvement in cellular signaling pathways and its regulation of the cytoskeleton make it a potential target for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, its unique genetic variation has made it an attractive target for researchers because it is relatively easy to modify to produce specific proteins that can interact with drugs.

In conclusion, BAF123 is a gene that has been identified as a potential drug target or biomarker for various diseases. Its unique genetic variation and involvement in cellular signaling pathways and the cytoskeleton make it an attractive target for researchers. Further studies are needed to determine its true potential as a therapeutic target.

Protein Name: Chromosome 10 Open Reading Frame 115

The "Chromosome 10 open reading frame 115 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Chromosome 10 open reading frame 115 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets